s6y
Company name or ticker
Search
CytomX Therapeutics, Inc.
D
Biotechnology offering of $30M, $30M sold
Filed
Thursday, August 17, 2023
Accession number
0001567619-23-006953
Documents
Exempt (Private) Offering
D
On sec.gov
Filing index
All files
Complete submission text
SGML header